Abou-Sleiman PM, Muqit MMK and Wood NW, ‘Expanding Insights of Mitochondrial Dysfunction in Parkinson’s Disease’ (2006) 7 Nature Reviews Neuroscience 207
Altshuler D, Daly MJ and Lander ES, ‘Genetic Mapping in Human Disease’ (2008) 322 Science 881
Antonarakis SE and Beckmann JS, ‘Mendelian Disorders Deserve More Attention’ (2006) 7 Nature Reviews Genetics 277
‘Atherosclerosis — An Inflammatory Disease — NEJM’
Balding DJ, ‘A Tutorial on Statistical Methods for Population Association Studies’ (2006) 7 Nature Reviews Genetics 781
Bishop, M., Cannings, C., and Balding, D. J., Handbook of Statistical Genetics (3rd ed, John Wiley 2007) <https://onlinelibrary.wiley.com/doi/book/10.1002/9781119487845>
Botstein D and Risch N, ‘Discovering Genotypes Underlying Human Phenotypes: Past Successes for Mendelian Disease, Future Approaches for Complex Disease’ (2003) 33 Nature Genetics 228
Bras JM and Singleton A, ‘Genetic Susceptibility in Parkinson’s Disease’ (2009) 1792 Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 597
Brinkman RR and others, ‘Human Monogenic Disorders — a Source of Novel Drug Targets’ (2006) 7 Nature Reviews Genetics 249
Burton, Paul, Palmer, Lyle, and Smith, George Davey, An Introduction to Genetic Epidemiology, vol Health&society series (Policy Press 2011)
Capecchi MR, ‘Essay: Gene Targeting in Mice: Functional Analysis of the Mammalian Genome for the Twenty-First Century’ (2005) 6 Nature Reviews Genetics 507
Daly AK, ‘Genome-Wide Association Studies in Pharmacogenomics’ (2010) 11 Nature Reviews Genetics 241
Foulkes, Andrea S., Applied Statistical Genetics with R: For Population-Based Association Studies, vol Use R! (Springer 2009)
Gibb, Alasdair J., Foreman, John C., and Johansen, Torben, Textbook of Receptor Pharmacology (3rd ed, CRC Press 2011)
Hall IP and Pirmohamed M, Pharmacogenetics (Taylor & Francis 2006) <https://doi.org/10.3109/9781420016697>
Hansson GK and Libby P, ‘The Immune Response in Atherosclerosis: A Double-Edged Sword’ (2006) 6 Nature Reviews Immunology 508
Hirschhorn JN and Daly MJ, ‘Genome-Wide Association Studies for Common Diseases and Complex Traits’ (2005) 6 Nature Reviews Genetics 95
Holmes MV, ‘CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular EventsA Systematic Review and Meta-Analysis’ (2011) 306 JAMA: The Journal of the American Medical Association
——, ‘Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies’ (2009) 4 PLoS ONE
——, ‘Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies’ (2009) 4 PLoS ONE
Humphries SE and Hingorani A, ‘Pharmacogenetics: Progress, Pitfalls and Clinical Potential for Coronary Heart Disease’ (2006) 44 Vascular Pharmacology 119
Kathiresan S and others, ‘Genome-Wide Association of Early-Onset Myocardial Infarction with Single Nucleotide Polymorphisms and Copy Number Variants’ (2009) 41 Nature Genetics 334
Kenakin, Terrence P., A Pharmacology Primer: Theory, Applications, and Methods (3rd ed, Elsevier Academic Press 2009) <https://www-sciencedirect-com.libproxy.ucl.ac.uk/book/9780123745859/a-pharmacology-primer>
Kirkwood, Betty R., Kirkwood, Betty R., and Sterne, Jonathan A. C., Essential Medical Statistics (2nd ed, Blackwell Science 2003)
Lee AJX and Swanton C, ‘Tumour Heterogeneity and Drug Resistance: Personalising Cancer Medicine through Functional Genomics’ (2012) 83 Biochemical Pharmacology 1013
Lefkowitz RJ, ‘Historical Review: A Brief History and Personal Retrospective of Seven-Transmembrane Receptors’ (2004) 25 Trends in Pharmacological Sciences 413
Lesk, Arthur M., Introduction to Bioinformatics (3rd ed, Oxford University Press 2008)
McCarthy MI and others, ‘Genome-Wide Association Studies for Complex Traits: Consensus, Uncertainty and Challenges’ (2008) 9 Nature Reviews Genetics 356
Neale, Benjamin M. and International Workshop of Twin and Family Studies, Statistical Genetics: Gene Mapping through Linkage and Association (Taylor & Francis 2008)
Neubig RR, ‘International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology’ (2003) 55 Pharmacological Reviews 597
‘New Perspectives for the Elucidation of Genetic Disorders’ <http://www.sciencedirect.com/science/article/pii/S0002929707611872>
O’Connor TP and Crystal RG, ‘Genetic Medicines: Treatment Strategies for Hereditary Disorders’ (2006) 7 Nature Reviews Genetics 261
Orengo, Christine Ann, Jones, David Tudor, and Thornton, Janet M., Bioinformatics: Genes, Proteins and Computers (BIOS 2003) <https://www.vlebooks.com/Product/Index/2052147?page=0&startBookmarkId=-1>
Ropers H-H, ‘New Perspectives for the Elucidation of Genetic Disorders’ (2007) 81 The American Journal of Human Genetics 199
Seifert R and Wenzel-Seifert K, ‘Constitutive Activity of G-Protein-Coupled Receptors: Cause of Disease and Common Property of Wild-Type Receptors’ (2002) 366 Naunyn-Schmiedeberg’s Archives of Pharmacology 381
Sham, P., Statistics in Human Genetics (Wiley 2007)
‘Table of Contents : Nature Reviews Genetics Focus on Monogenic Disorders’
Thomas, Duncan C., Statistical Methods in Genetic Epidemiology (Oxford University Press 2004)
Thompson AJ, Lester HA and Lummis SCR, ‘The Structural Basis of Function in Cys-Loop Receptors’ (2010) 43 Quarterly Reviews of Biophysics 449
Yusuf S and others, ‘Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (the INTERHEART Study): Case-Control Study’ (2004) 364 The Lancet 937
Zvelebil, Marketa J. and Baum, Jeremy O., Understanding Bioinformatics (Garland Science 2008) <https://bibliu.com/app/#/view/books/9781136976964/pdf2htmlex/index.html#page_Cover>
